Dark Pharma ยท DP-039

SHE WROTE THE ASSESSMENT IN 1984. THE PLANT KEPT DISCHARGING INTO THE AQUIFER. SHE KEPT HER CERTIFICATION.

Dr. Elena Marsh authored an alarming 1984 risk assessment documenting that C8 levels were significantly higher than acceptable thresholds, leading to probable carcinogenic risks for local residents. Despite this, Hexton Chemical continued its operations for nearly two decades without compliance measures being enacted.

Case Assets

The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.

Brief the Board PREMIUM
๐Ÿ”’ Unlock
Learn the Case FREE โ€” included
Study the Case PREMIUM
๐Ÿ”’ Unlock
Teach the Case PREMIUM
๐Ÿ”’ Unlock
Present the Case PREMIUM
๐Ÿ”’ Unlock
Run a Team Discussion PREMIUM
๐Ÿ”’ Unlock
Test Your Judgement PREMIUM
๐Ÿ”’ Unlock

Watch the Full Episode

The complete cinematic audio documentary โ€” Dark Pharma

Unlock the Full Case Library

Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment โ€” across a growing library of business cases.

View Pricing โ†’

Related Cases

Cases that share a governance or behavioural model with this one.